These results indicate that CCH can lead to decreased Nrf2 transportation to the nucleus and transcriptional function, and Nrf2 overexpression can assist in reducing cerebral ischemic injury and cognitive impairment in CCH models. The gene discussed is NFE2L2; the disease is columnar cell hyperplasia of the breast.